Albuterol Sulfate Solution
Brand names: Albuterol Sulfate, Albuterol Sulfate Inhalation Solution, 0.5%
Category: Pediatric, Pulmonary/Allergy
FDA status: Resolved · Last FDA update: Aug 27, 2026 · First posted: Oct 25, 2022 · 3 manufacturers, 3 listed presentations
As of Aug 27, 2026, the FDA lists Albuterol Sulfate Solution as shortage resolved. Of 3 manufacturer presentations, 3 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30) NDC 0487-9901-30 |
Nephron Pharmaceuticals Corporation | Not specified | - |
| Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03) NDC 64980-642-03 |
Rising Pharma Holdings, Inc. | Not specified | - |
| Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01) NDC 76204-027-01 |
Ritedose Pharmaceuticals, LLC | Not specified | - |
Related medications in shortage
Other Pediatric, Pulmonary/Allergy medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Albuterol Sulfate Solution (FDA data as of Aug 27, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Albuterol Sulfate Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/albuterol-sulfate-solution.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).